Parabon Nanolabs, Inc.
Reston, VA Part of Parabon Computation, Inc.
- UEI
- MXWGP7E3TFM8
- CAGE
- 593X1
- Primary NAICS
- 541713 Research and Development in Nanotechnology
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
Reston, VA
S8NEQVR3VFY7
-
Parent
Reston, VA
S8NEQVR3VFY7
- SAM.gov registration date
- Physical address
- 11260 Roger Bacon Dr #406, Reston, VA 20190, USA
- Website
- parabon-nanolabs.com
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $28,667 |
| FY2025 | $2,574,155 |
| FY2024 | $53,569 |
| FY2023 | $1,483,757 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Justice | $28,667 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Battelle National Biodefense Institute, LLC | HSHQDC15C00064 | $41,200 |
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Parabon Nanolabs, Inc., a small-business research and development contractor headquartered in Reston, Virginia, delivers DNA engineering, nanotechnology, forensic analytics, and biodefense capabilities to the Department of Defense, Department of Health and Human Services, and federal law enforcement agencies as a prime contractor on 98% of its recent awards, competing under total small business set-asides on SBIR Phase I and Phase II contracts.
Parabon's customer concentration tilts heavily toward defense and life-sciences research. The Department of the Army Materiel Command Research Development and Engineering Command (RDECOM) anchors the portfolio at 16 awards worth $14.3 million combined potential value, followed by the Defense Threat Reduction Agency at 7 awards worth $5.4 million, the Department of Defense Washington Headquarters Service at $3.7 million across two awards, and the Defense Health Agency at $1.6 million. The National Institutes of Health (National Institute of Allergy and Infectious Diseases and National Institute of General Medical Sciences) and the National Science Foundation round out the top five federal customers. The top five customers account for 56% of award count and 97% of combined potential value. Activity has declined from four awards in 2022 to two in 2026, with five awards totaling $2.9 million in combined potential value reaching ultimate completion inside the next twenty-four months and facing recompete exposure.
Parabon's capability portfolio centers on SBIR Phase II contracts for advanced nanocarrier systems, kinship analysis and pedigree reconstruction software, and gene-therapy delivery platforms. Representative work includes a $1.25 million Phase II SBIR contract from DTRA (awarded September 2025) for KIN-X, a pedigree reconstruction and kinship analysis capability completed by September 2027; a $1.099 million Phase II SBIR contract from Army RDECOM (awarded July 2022) for a nanoantibiotics platform designed to deliver antimicrobial peptides to lung tissue for treating pulmonary infections from aerosolized biothreat agents, completed January 2025; and a $1.1 million Phase II SBIR contract from DTRA (awarded February 2025) for engineering nanocarriers capable of transporting cargo across the blood-brain barrier, completed February 2027. Parabon also holds a $581,691 maintenance and support contract with the Defense Health Agency for the FX System (awarded September 2023, running through September 2028) and a $295,294 federal grant award from the National Institute of Allergy and Infectious Diseases (awarded June 2026) for METADX, a software platform leveraging whole metagenomic sequencing and machine learning to diagnose invasive fungal infections within 24 hours.
On the grant side, Parabon has received three federal grant awards from the National Institute of General Medical Sciences and the National Institute of Allergy and Infectious Diseases for gene-editing and DNA-nanotechnology research. A $295,294 NIAID grant (awarded June 2026) supports development of METADX for rapid fungal infection diagnosis. Earlier grants from NIGMS supported design of programmable, non-viral gene-therapy carriers using virus-inspired DNA origami (VIDO) vectors (awarded September 2023, $1.2 million equivalent scope, completed November 2025) and parametric design software for nanostructured CRISPR payloads to improve genome integration efficiency (awarded February 2023, completed April 2025). Parabon acts as prime recipient on all three grant awards.
The majority of Parabon's federal footprint lies in SBIR research and development contracts rather than service or production contracts. SCI-reportable invoicing from prime service contracts totaled $615 thousand across FY2022–FY2024, with deliveries of 0.3 FTEs in FY2022, 0.1 FTEs in FY2023, and 2.6 FTEs in FY2024. Government-paid hourly rates on SCI-reportable work ranged from $4.89/hr at the 10th percentile to a median of $24.44/hr, with senior labor priced through $93.66/hr at the 90th percentile. Parabon operates primarily as a prime on its federal work, with an average subcontractor-hours share of 3% across prime contracts and one named subcontractor in the SCI record. The company is a child entity within the Parabon Computation, Inc. corporate structure.
Quick answers
Is Parabon Nanolabs, Inc. registered in SAM.gov?
Yes. Parabon Nanolabs, Inc.'s SAM.gov registration is active through October 11, 2027.
What is Parabon Nanolabs, Inc.'s CAGE code?
Parabon Nanolabs, Inc.'s CAGE code is 593X1, and its Unique Entity ID (UEI) is MXWGP7E3TFM8.
How much has Parabon Nanolabs, Inc. received in federal contracts?
Federal contracts obligated $2,574,155 to Parabon Nanolabs, Inc. in fiscal year 2025 and $4,140,147 in fiscal years 2023 through 2027.
How does Parabon Nanolabs, Inc. rank among federal contractors?
Parabon Nanolabs, Inc. ranked #60 at the Defense Threat Reduction Agency in FY2025.
What is Parabon Nanolabs, Inc.'s most recent federal award?
Parabon Nanolabs, Inc.'s most recent federal contract award is Parabon low coverage imputation pipeline (15F06726P0000913), from Headquarters Division (FBI), on September 30, 2026.
On GovTribe
See Parabon Nanolabs, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors